Vireo Growth (VREOF) Market Cap to FCF (2020 - 2026)
Vireo Growth (VREOF) Market Cap to FCF (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Market Cap to FCF |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | 590.81 |
| 2 | Teva Pharmaceutical Industries | 35.94 Bn | 32.20 Bn | 1.97 Bn | 30.67 |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 14.55 |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | 3.94 |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | 16.20 |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | -0.07 |
| 7 | Viatris | 20.24 Bn | 18.43 Bn | 1.16 Bn | 11.29 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 21.18 |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | 39.97 |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | -552.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 23, 2026 | -555.78 |
| Jul 22, 2026 | -557.49 |
| Jul 21, 2026 | -554.64 |
| Jul 20, 2026 | -556.92 |
| Jul 17, 2026 | -556.92 |
| Jul 16, 2026 | -559.76 |
| Jul 15, 2026 | -567.71 |
| Jul 14, 2026 | -568.85 |
| Jul 13, 2026 | -565.44 |
| Jul 10, 2026 | -562.60 |
| Jul 9, 2026 | -562.60 |
| Jul 8, 2026 | -573.97 |
| Jul 7, 2026 | -567.15 |
| Jul 6, 2026 | -554.08 |
| Jul 2, 2026 | -565.44 |
| Jul 1, 2026 | -543.28 |
| Jun 30, 2026 | -570.56 |
| Jun 29, 2026 | -581.35 |
| Jun 26, 2026 | -567.15 |
| Jun 25, 2026 | -568.28 |